...
首页> 外文期刊>Bioanalysis >Effects of sialic acid linkage on antibody-fragment crystallizable receptor binding and antibody dependent cytotoxicity depend on levels of fucosylation/bisecting
【24h】

Effects of sialic acid linkage on antibody-fragment crystallizable receptor binding and antibody dependent cytotoxicity depend on levels of fucosylation/bisecting

机译:唾液酸连杆对抗体片段结晶受体结合和抗体依赖性细胞毒性的影响取决于岩藻糖基化/分数的水平

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Aim: Fragment crystallizable (Fc) glycosylation of immunoglobulin G-type monoclonal antibodies applied to therapeutic applications is regarded a critical quality attribute and can influence bioactivity, pharmacokinetics and/or immunogenicity/safety. Investigating the impact of certain Fc N-glycans is therefore of importance to assess its criticality for a therapeutic product. This has been done for N-glycan types like fucosylation, galactosylation or sialylation. There were contradictory results reported for functionality especially with regard to sialylation. Material & methods: We elucidated the effect of terminal sialic acid residues on Fc. receptor binding and antibody dependent cytotoxicity activity of two immunoglobulin G1 antibodies with different levels of fucosylation/bi-secting. Conclusion: We found the impact to be specific to the sialylation linkage type, in other words, alpha 2,3- versus alpha 2,6-linked sialic acid attached to the terminal galactose residues
机译:目的:用于治疗应用的免疫球蛋白G型单克隆抗体的片段可结晶(Fc)糖基化被认为是临界质量属性,可以影响生物活性,药代动力学和/或免疫原性/安全性。 研究某些Fc N-Glycans对某些Fc N-Glycans对治疗产品的关键性的重要性。 这是针对岩藻糖基化,半乳糖基化或唾液化等N-聚糖类型进行的。 有矛盾的结果报告了尤其是唾液化的功能。 材料和方法:我们阐明了末端唾液酸残基对Fc的影响。 具有不同水平的岩藻糖基化/双扇区的两种免疫球蛋白G1抗体的受体结合和抗体依赖性细胞毒性活性。 结论:我们发现对唾液酸化联动型特异性的影响,换句话说,附着于末端半乳糖残留物的α2,3-与α2,6-连接的唾液酸

著录项

  • 来源
    《Bioanalysis》 |2019年第15期|共13页
  • 作者单位

    Roche Diagnost GmbH Pharma Tech Dev Analyt Biol Nonnenwald 2 D-82377 Penzberg Germany;

    Roche Diagnost GmbH Pharma Tech Dev Analyt Biol Nonnenwald 2 D-82377 Penzberg Germany;

    Roche Diagnost GmbH Pharma Tech Dev Analyt Biol Nonnenwald 2 D-82377 Penzberg Germany;

    F Hoffmann La Roche Ltd Pharma Tech Dev Analyt Biol Grenzacherstr 124 CH-4070 Basel Switzerland;

    F Hoffmann La Roche Ltd Pharma Tech Dev Analyt Biol Grenzacherstr 124 CH-4070 Basel Switzerland;

    Roche Diagnost GmbH Pharma Tech Dev Analyt Biol Nonnenwald 2 D-82377 Penzberg Germany;

    Roche Diagnost GmbH Pharma Tech Dev Analyt Biol Nonnenwald 2 D-82377 Penzberg Germany;

    Roche Diagnost GmbH Pharma Tech Dev Analyt Biol Nonnenwald 2 D-82377 Penzberg Germany;

    F Hoffmann La Roche Ltd Pharma Tech Dev Analyt Biol Grenzacherstr 124 CH-4070 Basel Switzerland;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 生物科学;
  • 关键词

    ADCC; antibody; effector functions; fucosylation; in vitro glycoengineering; sialylation;

    机译:ADCC;抗体;效应器功能;岩藻糖基化;体外glycoenginering;唾液酸化;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号